Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
04.12.23
/
50%
€21.76
Target price
04.12.24
€26.71
Performance (%)
5.79%
Price
16.05.24
€23.02
Summary
This prediction is currently active. With a performance of 5.79%, the BUY prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 04.12.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | 12.622% | 12.622% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $29.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.47
02.01.24
02.01.24
€33.76
02.01.25
02.01.25
-19.14%
16.05.24
16.05.24